These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity. Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964 [TBL] [Abstract][Full Text] [Related]
52. Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease. Hu KC; Wang HY; Liu SC; Liu CC; Hung CL; Bair MJ; Liu CJ; Wu MS; Shih SC World J Gastroenterol; 2014 Jun; 20(24):7718-29. PubMed ID: 24976709 [TBL] [Abstract][Full Text] [Related]
53. The Future of Nonalcoholic Fatty Liver Disease Treatment. Mazhar K Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676 [TBL] [Abstract][Full Text] [Related]
55. Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α. Ajmal MR; Yaccha M; Malik MA; Rabbani MU; Ahmad I; Isalm N; Abdali N Indian Heart J; 2014; 66(6):574-9. PubMed ID: 25634387 [TBL] [Abstract][Full Text] [Related]
56. Understanding the association between developing a fatty liver and subsequent cardio-metabolic complications. Miele L; Targher G Expert Rev Gastroenterol Hepatol; 2015; 9(10):1243-5. PubMed ID: 26224399 [TBL] [Abstract][Full Text] [Related]
57. Cardiovascular Risk Reduction in Patients with Nonalcoholic Fatty Liver Disease: The Potential Role of Ezetimibe. Simon TG; Corey KE; Chung RT; Giugliano R Dig Dis Sci; 2016 Dec; 61(12):3425-3435. PubMed ID: 27714510 [TBL] [Abstract][Full Text] [Related]
58. Increased Risk for Cardiovascular Events in Patients with Diabetic Kidney Disease and Non-Alcoholic Fatty Liver Disease. Chinnadurai R; Chrysochou C; Kalra PA Nephron; 2019; 141(1):24-30. PubMed ID: 30384370 [TBL] [Abstract][Full Text] [Related]
59. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Targher G; Tilg H; Byrne CD Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):578-588. PubMed ID: 33961787 [TBL] [Abstract][Full Text] [Related]